NDAQ:CDXS - Post Discussion
Codexis Inc
> Codexis Licenses Genomics Life Science Enzyme Portfolio to A
Post by
whytestocks on Oct 01, 2024 8:31pm
Codexis Licenses Genomics Life Science Enzyme Portfolio to A
Just In: $CDXS Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciencesREDWOOD CITY, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into a non-exclusive commercial and manufacturing license agreement with Alphazyme LLC, part of Maravai LifeSciences, for multiple enzymes in ...
CDXS - Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
Be the first to comment on this post